NCT00207766View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

June 30, 2000

Study Completion Date

August 31, 2006

Conditions
Crohn Disease
Interventions
DRUG

infliximab or placebo

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY